Green tea as a therapeutic delivery system for anticancer drugs

April 15, 2015, Agency for Science, Technology and Research (A*STAR), Singapore
Green tea as a therapeutic delivery system for anticancer drugs
Catechin, a green tea derivative, has been combined with anticancer proteins to produce stable micellar nanocomplexes for the delivery of anticancer drugs such as Herceptin. Credit: bit245/iStock/Thinkstock

The humble cup of tea has long been regarded as a cure-all for the hustle and bustle of modern life. Now, researchers from the A*STAR Institute of Bioengineering and Nanotechnology have identified another benefit of tea—they have successfully used a major component of green tea, a catechin derivative, as the basis for a delivery system for anticancer drugs.

Delivering a drug to a targeted site in the body requires a 'carrier'—a compound that encases the drug. However, optimizing the drug-to-carrier ratio can be a major challenge. "This ratio is a stumbling block in carrier design because the carrier itself provides no therapeutic effect," explains Jackie Ying. "Furthermore, high quantities of the carrier may lead to problems associated with drug toxicity and metabolism."

To overcome this problem, Ying, along with Joo Eun Chung, Motoichi Kurisawa and other co-workers,  have designed a drug carrier that possesses therapeutic effects.

The scientists identified a catechin derivative in green tea known as epigallocatechin gallate (EGCG), which has documented , as the most promising carrier candidate. They used EGCG as the basis for 90-nanometer-diameter micellar nanocomplexes to deliver the anticancer protein drug Herceptin directly to tumors. The researchers did this by oligomerizing EGCG and then binding it to Herceptin, which formed the core of the micellar nanocomplexes. Finally, they formed the outer shells of the micellar nanocomplexes by binding polyethylene glycol–EGCG to the cores.

The team then tested the anticancer efficacy of the micellar nanocomplex both in vitro and in the body against a human breast cancer cell line and compared it with that of free Herceptin. The results were encouraging. "The carrier-delivered protein drugs significantly reduced tumor growth and were more effective against tumors  than the by itself," Chung reports.

Cancer is not the only potential target for this . "EGCG binds to many biological molecules, such as proteins, peptides and genes, and this is responsible for its many beneficial activities," notes Kurisawa. In particular, EGCG is known to be beneficial for cardiovascular and metabolic health; it also exhibits anti-HIV effects as well as neuro- and DNA-protective effects. "Our -based nanocarrier has the potential to deliver a variety of proteins, genes or drugs to improve the treatment of other diseases besides cancer," remarks Chung.

The team now intends to conduct clinical trials so that it will benefit cancer patients.

Explore further: Researchers develop green tea-based 'missiles' to kill cancer cells more effectively

More information: "Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy." Nature Nanotechnology 9, 907–912 (2014).

Related Stories

Recommended for you

What happened before the Big Bang?

March 26, 2019

A team of scientists has proposed a powerful new test for inflation, the theory that the universe dramatically expanded in size in a fleeting fraction of a second right after the Big Bang. Their goal is to give insight into ...

Cellular microRNA detection with miRacles

March 26, 2019

MicroRNAs (miRNAs) are short noncoding regulatory RNAs that can repress gene expression post-transcriptionally and are therefore increasingly used as biomarkers of disease. Detecting miRNAs can be arduous and expensive as ...

Race at the edge of the sun: Ions are faster than atoms

March 26, 2019

Scientists at the University of Göttingen, the Institut d'Astrophysique in Paris and the Istituto Ricerche Solari Locarno have observed that ions move faster than atoms in the gas streams of a solar prominence. The results ...

Physicists discover new class of pentaquarks

March 26, 2019

Tomasz Skwarnicki, professor of physics in the College of Arts and Sciences at Syracuse University, has uncovered new information about a class of particles called pentaquarks. His findings could lead to a new understanding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.